Bioorganic and Medicinal Chemistry Letters p. 4274 - 4276 (2015)
Update date:2022-08-11
Topics:
Chen, Zhe
Ku, Therese C.
Seley-Radtke, Katherine L.
The chemotherapeutic drug Gemcitabine, 2′,2′-difluoro-2′-deoxycytidine, has long been the standard of care for a number of cancers. Gemcitabine's chemotherapeutic properties stem from its 2′,2′-difluoro-2′-deoxyribose sugar, which mimics the natural nucleoside, but also disrupts nucleic acid synthesis, leading to cell death. As a result, numerous analogues have been prepared to further explore the biological implications for this structural modification. In that regard, a thieno-expanded guanosine analogue was of interest due to biological activity previously observed for the tricyclic heterobase scaffold. Several analogues were prepared, including the McGuigan ProTide, however the parent nucleoside exhibited the best chemotherapeutic activity, specifically against breast cancer cell lines (89.53% growth inhibition).
View MoreBeijing Huikang Boyuan Chemical Tech Co.,LTD
Contact:+86-10-68862197
Address:No.7 Haiying Road,Science City,Fengtai District,Beijing,China
Taizhou Chenyi chemical co. LTD,
Contact:13736652831
Address:NO.273 SHANGHAI SOUTH STREET,LUQIAO DISTRICT,ZHEJIANG PROVINCE,CHINA.
Contact:+86-535-8888888
Address:No.161 Haishi Rd.
Shanghai Potomer International Trade CO., LTD
Contact:+86-21-61397128
Address:Room 304,No.505 ,Caoyang Road.Shanghai,China
Chemtrade International ( China )
Contact:+86-532-86893005
Address:Rm 2-501, Huaxia Zonghe Building, No. 410 JInggangshan Road, Huangdao
Doi:10.1002/1521-3765(20000915)6:18<3377::AID-CHEM3377>3.0.CO;2-1
(2000)Doi:10.1166/jnn.2018.15499
(2018)Doi:10.1021/ja904377v
(2009)Doi:10.1007/s11172-013-0010-8
(2013)Doi:10.1002/anie.202006530
(2020)Doi:10.1021/jo01287a050
(1967)